Trials / Unknown
UnknownNCT04946565
The Impact of Sinopharm COVID-19 Vaccination on Male Fertility
The Impact of Sinopharm COVID-19 Vaccination on Male Fertility of the Egyptian Population
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Cairo University · Academic / Other
- Sex
- Male
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The investigators shall study the effect of Sinopharm vaccination on semen parameters and serum testosterone
Detailed description
The investigators shall compare semen parameter (sperm density, sperm motility, and percentage of abnormal sperm form) as well as morning serum testosterone before vaccination, and 3 months after the second dose of the vaccine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Semen analysis | Semen analysis according to WHO laboratory manual for the examination and processing of human semen, Fifth edition |
Timeline
- Start date
- 2021-07-03
- Primary completion
- 2022-06-30
- Completion
- 2022-08-30
- First posted
- 2021-07-01
- Last updated
- 2021-07-07
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04946565. Inclusion in this directory is not an endorsement.